Ritter Pharmaceuticals Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$3.68 |
Market Cap |
$9.72 M |
Shares Outstanding |
9.04 M |
Public Float |
4.37 M |
Address |
1880 Century Park East Los Angeles California 90067 United States |
Employees | - |
Website | http://www.ritterpharmaceuticals.com |
Updated | 07/08/2019 |
Ritter Pharmaceuticals, Inc. engages in the development of novel therapeutic products which modulate the human gut microbiome to treat gastrointestinal diseases. It focuses on the development and commercialization of RP-G28. The company was founded by Andrew J. |